Key points are not available for this paper at this time.
Section 2, “Classification and Diagnosis of Diabetes,” of the Standards of Care in Diabetes—2023 has been updated to refine the diagnostic criteria for type 1 diabetes based on recent U.S. Food and Drug Administration approval of a new drug to delay the incidence of type 1 diabetes.
ElSayed et al. (2023) studied this question.